Breakthrough Treatment for Allergic Rhinitis: Intratonsillar Injection Shows Promising Results in Clinical Trial Dr.Niharika Harsha B13 Dec 2023 3:00 AM ISTIn a groundbreaking clinical trial, researchers have discovered a novel approach to treating house dust mite (HDM)-induced allergic rhinitis (AR) that...
Intratonsillar Immunotherapy found efficacious in Allergic Rhinitis Dr. Shravani Dali11 Nov 2023 9:00 AM ISTIntratonsillar Immunotherapy found efficacious in Allergic Rhinitis in the latest trial suggests a new study published in the Annals of Allergy,...
Teplizumab Shows Promise in Preserving Beta-Cells in Early Type 1 Diabetes: PROTECT Trial Results Dr Riya Dave21 Oct 2023 10:00 AM ISTIn a recent study, researchers have found that early administration of teplizumab, marketed as Tzield, may help preserve beta-cells in individuals...
Systematic vitamin D supplementation improves outcomes among cancer patients on immune checkpoint inhibitors Dr. Kamal Kant Kohli30 Aug 2023 10:00 AM ISTItaly: Early systematic vitamin D supplementation may reduce thyroid adverse events and improve outcomes in cancer patients treated with immune...
Dual immunotherapy promising for treatment of recurrent or metastatic nasopharyngeal cancer Dr. Kamal Kant Kohli9 Jun 2023 9:30 AM ISTSingapore: The dual immunotherapy, PD-1 immune checkpoint inhibitor nivolumab and CTLA-4 targeting drug ipilimumab effectively treat recurrent or...
Rare case of Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy- A report Dr. Shravani Dali1 Jun 2023 8:00 PM ISTImmune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of several cancers. Pembrolizumab is an anti-programmed cell death-1...
Cemiplimab plus chemotherapy prolongs life and improves QoL in patients with advanced lung cancer Dr. Kamal Kant Kohli16 May 2023 11:00 AM ISTUSA: Cemiplimab plus chemotherapy can improve survival and also affects quality of life in patients with advanced lung cancer versus placebo...
Medical Bulletin 12/April/2023 Isra Zaman12 April 2023 4:00 PM ISTHere are the top medical news for the day:Pitt study shows mint flavor vape juice to be more toxic for lungsUsing a specially designed robotic system...
Immunotherapy response in advanced melanoma influenced by prior treatments: Study Isra Zaman12 April 2023 9:45 AM ISTWhen a patient is diagnosed with advanced melanoma, they usually are treated with immune therapies like anti-PD-1 blockade and anti-CTLA-4 blockade,...
Medical Bulletin 8/April/2023 Isra Zaman8 April 2023 4:45 PM ISTHere are the top medical news for the day:Study finds spread of COVID-19 in households to be linked to virus on hands and surfacesA new Imperial...
New immunotherapy agent safe and promising against high-risk prostate cancers Isra Zaman8 April 2023 9:15 AM ISTEnoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to...
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients Dr. Kamal Kant Kohli4 April 2023 10:00 AM ISTUSA: Immunotherapy after surgery increases the chance of staying cancer-free in bladder cancer patients compared to those who received a placebo,...
